期刊档案 · Reproductive, Female and Child Health
Reproductive, Female and Child Health
ISSN 2768-7228 · John Wiley & Sons, Inc. · USA
关注分区、影响因子、预警等有变化时邮件提醒
Reproductive, Female and Child Health 完全开放获取,APC 约 2,780 美元,近 24 个月 83 篇文章投稿到接收中位 157 天,录用比例约 29%(社区反馈),2025 年发文 39 篇。
研究范围
研究范围与定位
Reproductive, Female and Child Health 由 John Wiley & Sons, Inc. 出版。按 OpenAlex 近年发文统计,该刊主要发表 Maternal and Perinatal Health Interventions、Reproductive Health and Contraception、Global Maternal and Child Health 等主题的论文,这 3 个主题约占 33%,主导子领域为 Pediatrics, Perinatology and Child Health。(根据 OpenAlex 主题统计与中科院分区数据生成)
Reproductive, Female and Child Health (RFCH) is a multi-disciplinary journal that aims to improve clinical practice in reproductive, female, and child health. Journal content will highlight the interaction between preconception parental health, pregnancy, and fetal and child development. Reproductive health is a rapidly developing health care discipline, and its importance is recognized in the UN Sustainable Development Goals, which include targets to reduce global maternal, neonatal and child mortality and ensure universal access to reproductive healthcare services by 2030. The journal highlights the continuum of all related areas of reproductive health, including longitudinal studies from prior-to-conception to pre-school childhood, serving all disciplines in the reproductive health research community. The editors encourage contributions relating to human reproduction and reproductive systems, including male and female fertility, obstetrics, gynaecology, fetal and neonatal medicine, genetics, congenital disorders, and topics within paediatrics that relate to reproductive care. One of the overriding aims of RFCH is to support "Sound Science Criteria". This means that every piece of research that has been conducted in a sound and rigorous manner should be published somewhere. Sound science journals such as RFCH publish research on common but important issues, with a focus on quality rather than perceived novelty or (citation) impact. With sound science, the collective mission is to ensure there’s a home for every paper and to deliver rapid decisions for authors. Examples of research outputs include: Confirmatory research; Replication studies; Negative results; Research building on existing work. RFCH publishes a range of article types, including original research, systematic reviews, epidemiological studies, clinical trials, translational research, implementation science, quality improvement and commentaries. RFCH is a Wiley Open Access journal, one of a series of peer reviewed titles publishing quality research with speed and efficiency. For further information visit the Wiley Open Access website. RFCH accepts direct submissions as well as referrals from other Wiley titles.
摘自期刊官网 Aims & Scope
研究方向(LetPub):Reproductive, Female and Child Health
主编 Lucky Saraswat出版商官网
编委会国家分布:中国大陆 3 位(约 16%);主要国家 美国 4、中国 3、英国 3、意大利 3、加拿大 1(共 19 位编委标注了国家) 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Maternal and Perinatal Health InterventionsMedicine12.2%
- Reproductive Health and ContraceptionMedicine11.9%
- Global Maternal and Child HealthMedicine9%
- Maternal and Neonatal HealthcareHealth Professions6.7%
- Maternal and fetal healthcareMedicine5.5%
- Child Nutrition and Water AccessNursing4.8%
- Pregnancy and preeclampsia studiesMedicine4.2%
- Preterm Birth and ChorioamnionitisMedicine4.2%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
数据库收录
DOAJLetPub
国际期刊预警名单:各版本均未列入LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
- h-index
- 7OpenAlex ·
- i10-index
- 4OpenAlex ·
- 两年平均被引
- 0.79OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
- 年发文量(出版商公布) 2025
- 31出版商官网 ·
- 年下载量(出版商公布) 2025
- 65,969出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 223 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 61 | 61 | 118 |
| 2025 | 39 | 39 | 89 |
| 2024 | 51 | 51 | 42 |
| 2023 | 50 | 50 | 18 |
| 2022 | 22 | 22 | 1 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
157 天投稿到接收中位数 · P25–P75 106 天 – 220 天
- 接收到上线
- 中位数 17 天(84 篇)
- 投稿到上线
- 中位数 189 天
- 样本
- 83 篇有投稿与接收日期的文章(窗口内共 93 篇),最近一篇接收于
只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度(社区反馈)
- 期刊官网数据:平均Submission to first decision (median): 74 days;网友分享经验:LetPub ·
- 平均录用比例(社区反馈)
- 29%LetPub ·
- 录用率(出版商公布) 2025
- 29%出版商官网 ·
- 投稿到首次决定 2025
- 75 天出版商官网 ·
- 投稿到接收 2025
- 124 天出版商官网 ·
- 接收到发表 2025
- 20 天出版商官网 ·
- 投稿到发表(期刊自报)
- 约 7 周DOAJ ·
- 评审方式
- 单盲同行评审DOAJ
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,通常向作者收取文章处理费(APC)。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | USD 2,780 / GBP 2,100 / EUR 2,430 | 有 | CC BY | |
| OpenAlex | USD 2,650 / EUR 2,370 / GBP 2,100 | — | — | |
| 出版商官网 | 有,金额未公布 | — | — |
其他费用与减免(作者指南)
- 投稿费
- 无投稿费
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点2 项,摘自作者指南
- 关键词
- ≥ 1 个
- 参考文献格式
- AMA 格式
接收的文章类型10 种,含篇幅限制
- brief reportPurpose: To report results of a focused clinical trial. Required: Data Availability statement; IRB approval information; ethics statement; funding statement Wor…正文 ≤ 1,000 词 · 摘要 ≤ 250 词
- case reportPurpose: To describe a patient, or up to three patients, with a previously non-described or inconsistently described condition, presentation, course of disease …正文 ≤ 1,500 词 · 摘要 ≤ 200 词
- commentaryPurpose: evidence-based opinion pieces involving areas of broad interest as well as invited commentaries.Word limit: 1500 wordsAbstract: None Main manuscript: N…正文 ≤ 1,500 词
- editorialAll editorial decisions are considered final, although an appeals process is available. Decision options include: Desk rejection for papers that are out of scop…未说明篇幅
- letters to the editorPurpose: To comment on a paper published in an issue of the journal in the prior 12 weeks, either to raise concerns about the paper or to add commentary that fu…正文 ≤ 500 词
- original researchThe following is a list of article types, with the associated requirements for each type. Please submit the check lists for the publication guideline stipulated…未说明篇幅
- registered reportports, read the Wiley information here: Registered Reports Author Guidelines ) Word limit: Initial submission: 2000 words; Submission of results and discussion:…正文 ≤ 2,000 词 · 摘要 ≤ 250 词
- reviewThe following is a list of article types, with the associated requirements for each type. Please submit the check lists for the publication guideline stipulated…未说明篇幅
- surveyThe following is a list of article types, with the associated requirements for each type. Please submit the check lists for the publication guideline stipulated…未说明篇幅
- systematic reviewPurpose: To critically assess existing literature on a specific topic and if a meta-analysis is included to report outcomes when these studies are systematicall…正文 ≤ 5,000 词 · 摘要 ≤ 250 词
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、查重、预印本、试验注册 / 报告规范
- AI 使用 Use of Artificial Intelligence
该期刊认同COPE关于在研究和出版中使用人工智能的声明;AI工具(如ChatGPT等大语言模型)不能列为论文作者,因为它们无法满足作者身份要求、不能对投稿工作负责,作为非法律实体也无法声明利益冲突或管理版权与许可协议。 模型中文摘要
We endorse the COPE statements (https://publicationethics.org/cope-position-statements/ai-author) regarding the use of artificial intelligence (AI) in research and publications. AI tools (Examples: ChatGPT, other Large Language Models) cannot be listed as an author of a paper since these tools cannot meet the requirements for authorshipas they cannot take responsibility for the submitted work. As …
原文 ↗出版商官网 ·- 作者资格 Authorship
所有列名作者应对稿件有实质性贡献并同意最终投稿版本;所有作者须签署作者身份声明,确认符合ICMJE作者标准、采用CRediT格式并提供ORCID信息。 模型中文摘要
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review editorial standards and scroll down for a description of authorship criteria. All authors are required to sign an authorship declaration, affirming that they meet the ICMJE criteria for authorship, the CRedIT format and provide their ORCID ID information. After the subm…
原文 ↗出版商官网 ·- 利益冲突 Conflicts of Interest
所有作者须在投稿时识别潜在利益冲突或竞争利益;每位作者应下载并填写ICMJE表格,审稿人将被告知作者识别的相关利益冲突。 模型中文摘要
All authors must identify potential conflicts of interests or competing interests at the time of manuscript submission. The ICMJE form (http://www.icmje.org/disclosure-of-interest/) should be downloaded and completed by each author. Reviewers will be alerted to author-identified potentially relevant Conflicts of Interest.
原文 ↗出版商官网 ·- 数据可用性 Data Sharing, Data Availability and Data Citation
该期刊期望所有临床试验共享数据,并遵循ICMJE要求:2019年1月1日或之后开始招募受试者的临床试验须在注册中包含数据共享计划;作者须提供数据可用性声明,说明共享数据或无共享数据的情况,共享时须附存储库链接并引用数据。 模型中文摘要
This journal expects data sharing for all clinical trials and abides by the ICMJE requirement that clinical trials that begin enrolling participants on or after 1 January 2019 must include a data sharing plan in the trial's registration. The data supporting the results in the paper are expected to be archived in an appropriate public repository. Authors are required to provide a data availability …
原文 ↗出版商官网 ·- 出版伦理 Publication Misconduct
该期刊使用Wiley或COPE对出版不端行为的定义,并在出现不端指控时遵循COPE指南进行调查和处理;不端行为包括抄袭(窃取或挪用知识产权及未经署名的实质性文本复制)和文本重复等。 模型中文摘要
Several types of publication misconduct are known. Wiley has information about these various types of misconduct, and we use the Wiley definitions. (https://authorservices.wiley.com/ethics-guidelines/index.html#16) or COPE definitions. When allegations of misconduct occur, we follow COPE guidelines (https://publicationethics.org) for investigating and managing these allegations. Plagiarism: Includ…
原文 ↗出版商官网 ·- 许可与版权 Reproduction of Copyright Material
若稿件包含第三方版权作品的摘录,须在贡献中注明出处;通讯作者负责从原出版方获得以印刷及其他媒体复制材料的书面许可,并在投稿时向Wiley提供该许可。 模型中文摘要
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ. The corresponding author is responsible for obtaining written permission to reproduce the material "in print and …
原文 ↗出版商官网 ·- 开放获取 Open Access
该期刊为Gold开放获取期刊;稿件被接受并发表时将收取文章处理费(APC),作者可能通过机构、资助方或国家减免政策获得费用减免或折扣,出版费用或减免状态不影响编辑决策。 模型中文摘要
This journal is a Gold open access title. Submissions will be subject to an Article Processing Charge (APC) if accepted and published in the journal. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver. Publishing fees or waiver status do not influence editorial decision making.
原文 ↗出版商官网 ·- 同行评审 3. Submission and Peer Review Process
投稿意味着内容未在其他地方发表或投稿(科学会议或研讨会论文集中简短摘要除外);该期刊不收取投稿费,投稿问题可联系rfc.office@wiley.com;被接受发表时将收取文章处理费(APC)。 模型中文摘要
Submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This journal does not charge submission fees. For queries about submissions, please contact rfc.office@wiley.com Open Access This journal is a Gold open access title. Submissions will be subject to an Article Processin…
原文 ↗出版商官网 ·- 查重 Plagiarism Check
该期刊使用iThenticate的CrossCheck软件检测所有投稿稿件中重叠和相似文本的情况。 模型中文摘要
This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in all submitted manuscripts.
原文 ↗出版商官网 ·- 预印本 Preprint policy
该期刊考虑审阅曾以预印本形式发布的文章;作者须在标题页声明该论文曾以预印本发表并提供链接,否则可能在iThenticate查重时产生高相似度指数而延迟审稿;作者还应更新预印本版本并附最终发表文章的链接。 模型中文摘要
Reproductive, Female and Child Health will consider for review, articles previously available as preprints. Please communicate to the editorial team by including a statement on the title page that the paper has previously been published as a preprint and provide a link to it. Failure to do, will likely generate a high similarity index on the IThenticate plagiarism screen which will need to be inve…
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
ICMJE将临床试验定义为前瞻性地将人或人群分配到某种干预(无论有无对照或比较组)以研究健康相关干预与健康结果之间关系的研究项目;健康相关干预包括药物、手术、器械、行为治疗、教育项目、饮食干预、质量改进干预及诊疗流程改变等。 模型中文摘要
The International Committee of Medical Journal Editors define a clinical trial as “any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the relationship between a health-related intervention anda health outcome. Health-related interventions are those used to modify a biomedical or health-re…
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
投稿前准备
投稿 Reproductive, Female and Child Health 前的 5 项核对
- 1研究范围近年主要发表 Maternal and Perinatal Health Interventions、Reproductive Health and Contraception 等主题的论文。对照范围
- 2文章类型与格式关键词:≥ 1 个;参考文献格式:AMA 格式。作者指南 ↗
- 3英文表达投稿前通读一遍语法与学术写法,减少因语言问题被拒稿的风险,有助于提高录用机会。
- 4费用USD 2,780(DOAJ),有费用减免政策费用详情
- 5审稿时间预期157 天 · 投稿到接收中位数 · 近 24 个月 83 篇文章 · Crossref审稿统计
核对项由本页数据生成。
基本信息
出版信息与官方入口
- 出版商
- John Wiley & Sons, Inc.
- 出版国家或地区
- USA
- 出版语言
- English
- ISSN
- 2768-7228
- 官网最新一期
- Volume 5, Issue 3(2026 年 9 月)
- 官方链接
- 期刊主页 ↗LetPub
- 投稿系统 ↗出版商官网
- 作者指南 ↗LetPub
- Aims & Scope ↗DOAJ
- 专刊 / 特刊征稿 ↗出版商官网
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗DOAJ
- 编委会 ↗DOAJ
- 查重政策 ↗DOAJ
常见问题
关于 Reproductive, Female and Child Health 的常见问题
Reproductive, Female and Child Health 的审稿周期多长?
按 2024年11月至2026年11月(近 24 个月)83 篇已发表文章登记的日期,投稿到接收的中位数为 157 天(四分位 106–220 天);投稿社区反馈的平均审稿速度为期刊官网数据:平均Submission to first decision (median): 74 days;网友分享经验:,平均录用比例反馈为“29%”;期刊官网公布的录用率为 29%(2025)。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
Reproductive, Female and Child Health 的投稿格式要求是什么?
据期刊作者指南:关键词:≥ 1 个;参考文献格式:AMA 格式。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Reproductive, Female and Child Health 的编委会里有中国学者吗?
期刊官网编委会页面上标注了国家的 19 位编委中,中国大陆 3 位(约 16%);人数最多的国家是 美国(4 位)、中国(3 位)、英国(3 位)。统计按编委会页面列出的机构国家计,仅供参考。
Reproductive, Female and Child Health 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Reproductive, Female and Child Health 被 DOAJ 收录。
Reproductive, Female and Child Health 是开放获取期刊吗?版面费多少?
Reproductive, Female and Child Health 为完全开放获取。APC 约 2,780 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。